Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Heery Insider Profile
4 Followers
Christopher Heery, CMO at Precision BioSciences, holds 9.28K shares in Arcellx Inc (Ticker: ACLX), holds 2.48K shares in Precision BioSciences (Ticker: DTIL).
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-48.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Christopher Heery
Christopher Heery's Trading History
Precision BioSciences
Dec 20, 2019
CMO
Informative Buy
30.02K
$11.73K
Arcellx Inc
Sep 06, 2024
CMO
Uninformative Buy
51.31K
$700.86K
List of latest transactions for each holding click on a transaction to see Christopher Heery's performance on stock
You May Also Like
Christopher Heery insider profile FAQ
What is the percentage of profitable transactions made by Christopher Heery?
The percentage of profitable transactions made by Christopher Heery is 0%.
What is the average return per transaction made by Christopher Heery?
The average return per transaction made by Christopher Heery is -48.00%.
What stocks does Christopher Heery hold?
Christopher Heery holds: DTIL, ACLX stocks.
What was Christopher Heery’s latest transaction?
Christopher Heery latest transaction was an Uninformative Buy of $51.31K.
What was Christopher Heery's most profitable transaction?
Christopher Heery’s most profitable transaction was an Informative Sell of ACLX stock on February 12, 2024. The return on the trade was -30.90%.
What is Christopher Heery's role in Precision BioSciences?
Christopher Heery's role in Precision BioSciences is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.